Cargando…

Genetic Testing in Patients with Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with an estimated prevalence of up to 1 in 200 individuals. In the majority of cases, HCM is considered a Mendelian disease, with mainly autosomal dominant inheritance. Most pathogenic variants are usually detected in genes for sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonaventura, Jiri, Polakova, Eva, Vejtasova, Veronika, Veselka, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509044/ https://www.ncbi.nlm.nih.gov/pubmed/34638741 http://dx.doi.org/10.3390/ijms221910401

Ejemplares similares

The utility of the Mayo Score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy
por: Bonaventura, Jiří, et al.
Publicado: (2018)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy and bilateral lung transplantation for idiopathic pulmonary fibrosis: a case report
por: Puchnerova, Veronika, et al.
Publicado: (2023)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Jahnlová, Denisa, et al.
Publicado: (2019)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy
por: Zemanek, David, et al.
Publicado: (2015)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
por: Colombo, Maria Giovanna, et al.
Publicado: (2008)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

TAVI-in-TAVI in a patient after alcohol septal ablation
por: Polaková, Eva, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy: An Overview of Genetics and Management
por: Teekakirikul, Polakit, et al.
Publicado: (2019)

Gene database for the development of genetic testing for hypertrophic cardiomyopathy
por: Silas, Justin Carlus, et al.
Publicado: (2014)

The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy
por: Mikic, Lidija, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Krejci, Jan, et al.
Publicado: (2013)

Predictors of long-term survival in patients treated with targeted temperature management after cardiac arrest
por: Bonaventura, Jiří, et al.
Publicado: (2019)

Thromboembolism in Patients with Hypertrophic Cardiomyopathy
por: Liu, Lu, et al.
Publicado: (2021)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Left ventricular reverse remodelling and its predictors in non‐ischaemic cardiomyopathy
por: Hnat, Tomas, et al.
Publicado: (2022)

Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions
por: Girolami, Francesca, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers
por: Glavaški, Mila, et al.
Publicado: (2023)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Genetic Test for Dilated and Hypertrophic Cardiomyopathies: Useful or Less Than Useful for Patients?
por: Pastore, F, et al.
Publicado: (2013)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

History and current use of mild therapeutic hypothermia after cardiac arrest
por: Bonaventura, Jiří, et al.
Publicado: (2016)

Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy
por: Chou, Chun, et al.
Publicado: (2023)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy
por: Roma-Rodrigues, Catarina, et al.
Publicado: (2014)

Mid-term outcomes of patients with Lotus and Evolut transcatheter valves
por: Hájek, Petr, et al.
Publicado: (2022)

Heart transplantation in patients with hypertrophic cardiomyopathy
por: Torres, Marta Farrero, et al.
Publicado: (2018)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Clinical predictors of a positive genetic test in hypertrophic cardiomyopathy in the Brazilian population
por: Marsiglia, Julia Daher Carneiro, et al.
Publicado: (2014)

Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results
por: Smagarinsky, Yana, et al.
Publicado: (2017)

Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
por: Vosberg, Hans-Peter
Publicado: (2000)

Genetic profile of hypertrophic cardiomyopathy in Tunisia: Is it different?
por: Jaafar, Nawel, et al.
Publicado: (2015)

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
por: Velicki, Lazar, et al.
Publicado: (2020)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3flttiequ967paeqja5gh30a84